Your browser doesn't support javascript.
loading
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies.
Lutz, Emi A; Agarwal, Yash; Momin, Noor; Cowles, Sarah C; Palmeri, Joseph R; Duong, Ellen; Hornet, Vladlena; Sheen, Allison; Lax, Brianna M; Rothschilds, Adrienne M; Irvine, Darrell J; Spranger, Stefani; Wittrup, K Dane.
  • Lutz EA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Agarwal Y; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Momin N; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Cowles SC; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Palmeri JR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Duong E; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Hornet V; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Sheen A; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Lax BM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Rothschilds AM; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Irvine DJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Spranger S; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Wittrup KD; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Proc Natl Acad Sci U S A ; 119(36): e2205983119, 2022 09 06.
Article en En | MEDLINE | ID: mdl-36037341

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Hidróxido de Aluminio / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Hidróxido de Aluminio / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article